Prefilled Syringes Market is Expanding At A CAGR Of 11.95% From 2022 To 2030

 Prefilled Syringes Industry Overview

The global prefilled syringes market size was valued at USD 18.43 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 11.95% from 2022 to 2030. Growing demand for efficient and easy-to-use drug delivery devices and increasing efforts of healthcare professionals to reduce hospital errors are the principal factors driving the market growth. The fast-paced development of feature-rich devices with underlying technological advancements extending safer and convenient self-injections for patients coupled with the impact of COVID-19 is expected to fuel the market growth during the forecast period.

With the current COVID - 19 outbreaks, a huge surge in immunizations is expected around the world. COVID-19 has spurred the development of prefilled syringes, especially for low-temperature storage. For instance, in September 2021, by demonstrating their glass prefilled syringes, which are ideal for use with mRNA doses that must be stored at ultralow temperatures, BD has positioned itself to unlock a new COVID-19 vaccination opportunity. BD also analyzed 2,000 syringes that were maintained at minus 20 and minus 40 degrees Celsius to see how temperatures affected the delivery devices. Moreover, syringes with various glass barrel coatings, volumes, and other variables that could influence the response to deep cold storage were investigated. As a result, due to the outbreak of the COVID-19 pandemic in 2020, sales of prefilled syringes increased globally.

Gather more insights about the market drivers, restrains and growth of the Global Prefilled Syringes market

A steep rise in the development of biological therapies is expected to boost industry growth. Biologic drugs including therapeutic vaccines are rapidly replacing the traditional therapeutic options owing to their increased efficiency, efficacy as well as patient safety with reduced side effects. The constant introduction of biologic drugs has given rise to the demand for innovative packaging solutions to maintain the potency of these drugs as they are extremely unstable. More than 60% of the biologic drugs are currently in the pipeline and preferred with parenteral administration as any interaction with food and digestive enzymes results in their deterioration. Thus, prefilled syringes are considered to be an ideal container for the storage of such drugs. Moreover, the growth of the biologic drug market has a direct positive impact on the prefilled syringes market.

Needlestick injuries are potentially dangerous as they may lead to the transmission of fatal diseases such as HIV and Hepatitis. For instance, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS) in June 2021, 37.7 million [30.2 million–45.1 million] individuals worldwide were living with HIV in 2020. Additionally, according to the same source, 28.2 million people had access to antiretroviral therapy as of June 2021 which is anticipated to boost the industry growth. Moreover, patients, as well as physicians are at a high risk of developing needle stick injuries during dose preparation. For instance, in March 2021, according to Occupation Safety and Health Administration (OSHA), every year, two million healthcare professionals (out of a total of 35 million) suffer from accidental needle-stick wounds around the world which are anticipated to boost the business scale in the ensuing years.

Furthermore, the Centers for Disease Control and Prevention (CDC) believes that using safety measures like prefilled syringes in hospitals might reduce sharps-related injuries by 60-88 %. This is because prefilled syringes are an easy way to reduce these injuries as the application of these devices bypasses the various dose preparation steps and can easily be disposed of. In the case of self-injection systems, innovative modifications such as hidden needles are helpful in reducing such injuries, resulting in increased patient convenience. As prefilled syringes provide safety without the added price, the usage of the same is expected to increase in the future.

Along with the aforementioned factors, a growing number of approvals for prefilled syringes by regulatory bodies, such as the U.S., FDA, and the EU along with market expansion is predicted to actively contribute to industry expansion. For instance, in September 2022, Owen Mumford Pharmaceutical Services, a company of Owen Mumford Ltd., received approval as a combination product in Asia for their safety device which is named 1mL UniSafe for pre-filled syringes. 1mL UniSafe has also received regulatory approval in Europe and the medicine is currently available on the market as a combination product with a rheumatoid arthritis drug. Moreover, 1mL UniSafe is a revolutionary, spring-free, patented safety mechanism for prefilled syringes that delivers a variety of benefits to both pharmaceutical firms and their patients which is anticipated to increase the demand for prefilled syringes in near future.

The growing popularity of auto-injectors owing to their advantages such as patient convenience and minimal contamination are factors that are expected to boost their growth during the period in focus. For instance, in July 2021, following the complete conclusion of development, Owen Mumford Pharmaceutical Services unveiled its innovative Aidaptus auto-injector platform. Aidaptus is a two-step, single-use auto-injector, spring-powered with a versatile design that fits both 2.25 mL and 1 mL prefilled glass syringes in the same base device, which is projected to drive market growth in the near future.

Increasing government investments in cutting-edge syringe production will drive market growth in the near future. For instance, in March 2022, the investment of USD 84.53 million in Hungary is intended to address the expanding global demand for prefill-able glass syringes. The extension is set to be complete by 2024 and it is expected to support the demand for the product in the near future.


Browse through Grand View Research's Medical Devices Industry Research Reports.

  • Electronic Skin Market - The global electronic skin market size was valued at USD 4.5 billion in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 20.5% from 2020 to 2027.
  • Ureteral Stents Market - The global ureteral stents market size was valued at USD 422.9 million in 2019 and is expected to grow at a compound annual growth rate (CAGR) of 7.0% from 2020 to 2027.

Prefilled Syringes Market Segmentation

Grand View Research has segmented the global prefilled syringes market on the basis of type, material, application, distribution channel, and regions: 

Type Outlook (Revenue, USD Million, 2017 - 2030)

  • Disposable Prefilled Syringes
  • Reusable Prefilled Syringes

Material Outlook (Revenue, USD Million, 2017 - 2030)

  • Glass Prefilled Syringes
  • Plastic Prefilled Syringes

Application Outlook (Revenue, USD Million, 2017 - 2030)

  • Anaphylaxis
  • Rheumatoid Arthritis
  • Diabetes
  • Others

Distribution Channel Outlook (Revenue, USD Million, 2017 - 2030)

  • Hospitals
  • Mail Order Pharmacies
  • Ambulatory Surgery Centers

Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Market Share Insights

  • August 2021: SCHOTT AG, a German specialty glass business along with its latest partnerSerum Institute of India purchased a 50% stake in the SCHOTT Kaisha joint venture in India.
  • April 2021: Packaging Nipro Pharma CURACASE was introduced which is an individually packaged product in a compact and well-designed hard-plastic packaging that takes up the least amount of space in secondary packaging.

 

Key Companies profiled:

Some prominent players in the global prefilled syringes market include:

  • Gerresheimer AG
  • Schott Group
  • Unilife Corporation
  • Nipro Medical Corporation
  • Owen Mumford
  • Haselmeier AG
  • BD & Others

 

Order a free sample PDF of the Prefilled Syringes Market Intelligence Study, published by Grand View Research.

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:

Sherry James

Corporate Sales Specialist, USA

Grand View Research, Inc.

Phone: 1-415-349-0058

Toll Free: 1-888-202-9519

Email: sales@grandviewresearch.com

Web: https://www.grandviewresearch.com

Follow Us: LinkedIn | Twitter

 

Comments

Post a Comment

Popular posts from this blog

Drug Addiction - Pipeline Review, H1 2017 Market Overview and trends research report

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p...
Read more

All Countries Dialyzer Industry 2013-2028 - Market Size, Share, Outlook, Growth, Key Players and Forecast

The global Dialyzer market was valued at $XX million in 2018, and Radiant Insights, Inc analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for Dialyzer from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Dialyzer market. Download Free Sample Report @ https://www.radiantinsights.com/research/2013-2028-report-on-global-dialyzer-market/request-sample Leading players of Dialyzer including: • Fresenius Medical Care • Baxter • Nipro • Asahi Kasei • Toray • B.Braun • Nikkiso • Medtronic • Kawasumi • Medica • Wego • Lengthen • Peony Medical • Chengdu OCI • Bain Medical Equipment Market split by Type, can be divided into: • Flat Type Dialyzer • Coil Tube Dialyzer • Ho...
Read more

Insights into the Medical Waste Disposal Category: A Comprehensive Procurement Intelligence Report

  Medical Waste Disposal Category Overview The medical waste disposal category is anticipated to grow at a CAGR of 6.0% from 2023 to 2030. Appropriate disposal of medical trash is the key challenge for healthcare providers across the globe. Rising awareness about the benefits of proper medical waste management for treatment, recycling, and disposal of medical trash has boosted the growth of the category. According to the World Health Organization Study Report 2022, countries with low income generate over 0.2 kg of medical trash per day per hospital bed, whereas countries with high income generate hazardous waste of up to 0.5 kg per hospital bed each day. Moreover, rising government initiatives and strict rules and regulations for waste management are also expected to drive the category. For instance, in December 2022, an MOU was signed between the Center for Health Environment Research and Development and Can Tho Central General Hospital under USAID’s Reducing Pollution Project. T...
Read more